GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » Cyclically Adjusted Price-to-FCF

Sartorius AG (Sartorius AG) Cyclically Adjusted Price-to-FCF : 100.00 (As of Apr. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sartorius AG Cyclically Adjusted Price-to-FCF?

As of today (2024-04-28), Sartorius AG's current share price is $248.00. Sartorius AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $2.48. Sartorius AG's Cyclically Adjusted Price-to-FCF for today is 100.00.

The historical rank and industry rank for Sartorius AG's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SARTF' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 87.28   Med: 287.31   Max: 664.96
Current: 99.99

During the past years, Sartorius AG's highest Cyclically Adjusted Price-to-FCF was 664.96. The lowest was 87.28. And the median was 287.31.

SARTF's Cyclically Adjusted Price-to-FCF is ranked worse than
79.91% of 229 companies
in the Medical Devices & Instruments industry
Industry Median: 42.33 vs SARTF: 99.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sartorius AG's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $-1.301. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $2.48 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sartorius AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Cyclically Adjusted Price-to-FCF Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 397.76 481.58 358.26 169.34 110.76

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.69 121.07 121.58 110.76 121.13

Competitive Comparison of Sartorius AG's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted Price-to-FCF falls into.



Sartorius AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sartorius AG's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=248.00/2.48
=100.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sartorius AG's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.301/123.6675*123.6675
=-1.301

Current CPI (Mar. 2024) = 123.6675.

Sartorius AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.072 99.543 -0.089
201409 0.140 99.823 0.173
201412 0.700 99.543 0.870
201503 -0.120 99.717 -0.149
201506 0.384 100.417 0.473
201509 0.136 100.417 0.167
201512 -0.159 99.717 -0.197
201603 -0.172 100.017 -0.213
201606 -0.704 100.717 -0.864
201609 -1.525 101.017 -1.867
201612 2.209 101.217 2.699
201703 -0.223 101.417 -0.272
201706 -0.172 102.117 -0.208
201709 0.229 102.717 0.276
201712 0.386 102.617 0.465
201803 -0.028 102.917 -0.034
201806 -0.092 104.017 -0.109
201809 0.262 104.718 0.309
201812 0.051 104.217 0.061
201903 0.819 104.217 0.972
201906 0.010 105.718 0.012
201909 0.559 106.018 0.652
201912 1.088 105.818 1.272
202003 1.100 105.718 1.287
202006 0.957 106.618 1.110
202009 2.061 105.818 2.409
202012 0.465 105.518 0.545
202103 2.558 107.518 2.942
202106 2.554 108.486 2.911
202109 1.760 109.435 1.989
202112 1.153 110.384 1.292
202203 1.550 113.968 1.682
202206 -0.406 115.760 -0.434
202209 0.499 118.818 0.519
202212 1.655 119.345 1.715
202303 1.045 122.402 1.056
202306 -0.067 123.140 -0.067
202309 0.742 124.195 0.739
202312 2.953 123.668 2.953
202403 -1.301 123.668 -1.301

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius AG  (OTCPK:SARTF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sartorius AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (Sartorius AG) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Sartorius AG (Sartorius AG) Headlines